In addition, we found that aggressive breast cancer cell phenotypes were recovered when the TGF-β/Smad signalling pathway was specifically arrested in SGMS2 overexpression cells by pirfenidone, and the expression of EMT-related markers was also reversed. Here, SGMS2 is linked to breast carcinoma.